Yee Ting (Esther) Chong

Title: Innovations by Yee Ting (Esther) Chong

Introduction

Yee Ting (Esther) Chong is a notable inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of two patents to her name, her work focuses on innovative methods for modulating neuropilin-2 (NRP2) activity.

Latest Patents

Chong's latest patents include compositions and methods comprising anti-NRP2 antibodies. These patents provide antibodies and antigen-binding fragments that specifically bind to human neuropilin-2 (NRP2) polypeptides. The inventions aim to modulate binding interactions between human NRP2 and its ligands, such as human histidyl-tRNA synthetase (HRS). This modulation can influence downstream signaling events related to NRP2, offering potential therapeutic applications for treating NRP2-associated diseases.

Career Highlights

Chong is currently employed at Atyr Pharma, Inc., where she continues to advance her research in antibody development. Her work is pivotal in exploring new therapeutic avenues for diseases linked to NRP2.

Collaborations

Chong collaborates with talented colleagues, including Luke Burman and Yanyan Geng, who contribute to her research efforts and innovations.

Conclusion

Yee Ting (Esther) Chong's contributions to biotechnology through her patents and work at Atyr Pharma, Inc. highlight her role as an influential inventor in the field. Her research on anti-NRP2 antibodies has the potential to lead to significant advancements in therapeutic treatments.